Access this article Similar content being viewed by others References Aitken RJ, Smith TB, Jobling MS et al (2014) Oxidative stress and male reproductive health
12: Jzwiak M, Bauer M, Kamysz W, Kleczkowska P
Currently, most clinically approved therapeutics are small molecules or protein/antibody biologics
In vitro, apigenin inhibited -hexosaminidase and histamine release in a noncytotoxic manner [134]
It achieves this by enhancing blood flow through angiogenesis, the formation of new blood vessels, which is essential for supplying nutrients and oxygen to injured areas and removing waste and inflammatory byproducts[2][5]
These interventions require minimal additional provider time while ensuring systematic assessment (Grundstrm et al., 2018)